Prediction model establishment of prognosis factors for distant metastasis of hepatocellular carcinoma based on the SEER database

被引:0
作者
Wu, Jixuan [1 ,4 ]
Zhang, Chun [1 ,4 ]
Zhang, Youjia [5 ]
He, Rui [2 ]
Wang, Qin [3 ]
Zhang, Lei [1 ]
Hu, Jing [2 ]
Wan, Runlan [2 ,4 ]
机构
[1] Southwest Med Univ, Sch Pharm, Luzhou 646000, Sichuan, Peoples R China
[2] Southwest Med Univ, Affiliated Hosp, Dept Oncol, Luzhou 646000, Sichuan, Peoples R China
[3] Dazhou Vocat Coll Chinese Med, Dazhou 635000, Peoples R China
[4] Southwest Med Univ, Sch Pharm, Dept Pharmacol, Key Lab Luzhou City Aging Med, Luzhou 646000, Peoples R China
[5] Southwest Med Univ, Sch Publ Hlth, Luzhou 646000, Peoples R China
关键词
Nomogram; Hepatocellular carcinoma; Distant metastasis; SEER; NANOPARTICLES; THERAPY;
D O I
10.1016/j.canep.2024.102729
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Distant metastasis in hepatocellular carcinoma (HCC) is an important indicator of poor patient prognosis. Identifying patients who are at high risk of metastasis early on is essential for creating personalized treatment plans, yet currently, there is a scarcity of effective predictive tools. Objective: To investigate the effects of different factors on distant metastasis in HCC patients and to establish a clinical prediction model for predicting distant metastasis in HCC patients. Methods: Our study retrospectively examined 22,318 patients diagnosed with confirmed HCC from the SEER database. Prognostic factors for developing distant metastases in HCC patients were identified by univariate and multivariate logistic regression analyses. Utilizing data from a multivariate logistic regression analysis, we created a nomogram. Its predictive precision was evaluated by analyzing the calibration curve, the area under the curve (AUC) of the receiver operating characteristic curve, decision curve assessment (DCA), and KaplanMeier (KM) curve analysis of overall survival. Finally,the nomogram was visualized with an online calculator. Results: We identified six independent prognostic factors: ethnicity, marital status, tumor size, survival time, surgery, and radiotherapy. The nomogram constructed from these six factors showed good calibration, discrimination, and clinical application value after calibration curve analysis, receiver operating characteristic curve analysis and DCA curve analysis. Besides, Kaplan-Meier survival curves also demonstrated that this nomogram had predictive accuracy. Conclusion: In this research, a nomogram model was created to accurately predict distant metastasis risk in patients with HCC. This study provides guidance for optimizing individual therapies and making better clinical decisions.
引用
收藏
页数:7
相关论文
共 34 条
  • [1] Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion
    Cai, Zhixiong
    Su, Xiaoping
    Qiu, Liman
    Li, Zhenli
    Li, Xiaolou
    Dong, Xiuqing
    Wei, Fuqun
    Zhou, Yang
    Luo, Liuping
    Chen, Geng
    Chen, Hengkai
    Wang, Yingchao
    Zeng, Yongyi
    Liu, Xiaolong
    [J]. MOLECULAR CANCER, 2021, 20 (01)
  • [2] DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma
    Chen, Yunfei
    Wang, Xu
    Deng, Xiaofan
    Zhang, Yu
    Liao, Rui
    Li, Youzan
    Yang, Hongji
    Chen, Kai
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [3] Real-World Data on Clinical Outcomes of Patients with Liver Cancer: A Prospective Validation of the National Cancer Centre Singapore Consensus Guidelines for the Management of Hepatocellular Carcinoma
    Chew, Xin Hui
    Sultana, Rehena
    Mathew, Eshani N.
    Ng, David Chee Eng
    Lo, Richard H. G.
    Toh, Han Chong
    Tai, David
    Choo, Su Pin
    Goh, Brian Kim Poh
    Yan, Sean Xuexian
    Loke, Kelvin Siu Hoong
    Thang, Sue Ping
    Gogna, Apoorva
    Venkatanarasimha, Nanda Karaddi
    Tong, Aaron K. T.
    Moe, Fiona N. N.
    Chua, Jacelyn S. S.
    Ang, Reiko W. T.
    Ong, Aldwin D.
    Ng, Ashley W. Y.
    Hoang, Marjorie T. Q.
    Too, Chow Wei
    Thng, Choon Hua
    Chan, Wan Ying
    Kee, Wanyi
    Chan, Jaclyn H. M.
    Irani, Farah
    Leong, Sum
    Lim, Kiat Hon
    Wang, Michael L. C.
    Chow, Pierce K. H.
    [J]. LIVER CANCER, 2021, 10 (03) : 224 - 239
  • [4] Combined Transarterial Embolization/Chemoembolization-Based Locoregional Treatment with Sorafenib Prolongs the Survival in Patients with Advanced Hepatocellular Carcinoma and Preserved Liver Function: A Propensity Score Matching Study
    Chien, Shih-Chieh
    Chen, Chiung-Yu
    Cheng, Pin-Nan
    Liu, Yi-Shan
    Cheng, Hsiu-Chi
    Chuang, Chiao-Hsiung
    Chang, Ting-Tsung
    Chiu, Hong-Chi
    Lin, Yih-Jyh
    Chiu, Yen-Cheng
    [J]. LIVER CANCER, 2019, 8 (03) : 186 - 202
  • [5] KSR2-14-3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma
    Gao, Chao
    Wang, Si-wei
    Lu, Jia-cheng
    Chai, Xiao-qiang
    Li, Yuan-cheng
    Zhang, Peng-fei
    Huang, Xiao-yong
    Cai, Jia-bin
    Zheng, Yi-min
    Guo, Xiao-jun
    Shi, Guo-ming
    Ke, Ai-wu
    Fan, Jia
    [J]. BIOMARKER RESEARCH, 2022, 10 (01)
  • [6] Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma
    Gigante, Elia
    Hobeika, Christian
    Le Bail, Brigitte
    Paradis, Valerie
    Tougeron, David
    Lequoy, Marie
    Bouattour, Mohamed
    Blanc, Jean-Frederic
    Ganne-Carrie, Nathalie
    Tran, Henri
    Hollande, Clemence
    Allaire, Manon
    Amaddeo, Giuliana
    Regnault, Helene
    Vigneron, Paul
    Ronot, Maxime
    Elkrief, Laure
    Verset, Gontran
    Trepo, Eric
    Zaanan, Aziz
    Ziol, Marianne
    Ningarhari, Massih
    Calderaro, Julien
    Edeline, Julien
    Nault, Jean-Charles
    [J]. LIVER CANCER, 2022, 11 (05) : 460 - 473
  • [7] Improved Delivery Performance of n-Butylidenephthalide-Polyethylene Glycol-Gold Nanoparticles Efficient for Enhanced Anti-Cancer Activity in Brain Tumor
    Hsing, Ming-Tai
    Hsu, Hui-Ting
    Chang, Chih-Hsuan
    Chang, Kai-Bo
    Cheng, Chun-Yuan
    Lee, Jae-Hwan
    Huang, Chien-Li
    Yang, Meng-Yin
    Yang, Yi-Chin
    Liu, Szu-Yuan
    Yen, Chun-Ming
    Yang, Shun-Fa
    Hung, Huey-Shan
    [J]. CELLS, 2022, 11 (14)
  • [8] The variable association between expression and methylation of estrogen receptors and the survival of patients with different tumors
    Hu, Chao
    Liu, Yinhua
    Jiang, Shan
    Chen, Hongjin
    Xu, Haojun
    Hu, Junhong
    Li, Congzhu
    Xia, Hongping
    [J]. CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (02):
  • [9] Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis
    Huang, Xiao-Yong
    Zhang, Peng-Fei
    Wei, Chuan-Yuan
    Peng, Rui
    Lu, Jia-Cheng
    Gao, Chao
    Cai, Jia-Bing
    Yang, Xuan
    Fan, Jia
    Ke, Ai-Wu
    Zhou, Jian
    Shi, Guo-Ming
    [J]. MOLECULAR CANCER, 2020, 19 (01)
  • [10] Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinoma
    Liu, Sai-Lan
    Bian, Li-Juan
    Liu, Ze-Xian
    Chen, Qiu-Yan
    Sun, Xue-Song
    Sun, Rui
    Luo, Dong-Hua
    Li, Xiao-Yun
    Xiao, Bei-Bei
    Yan, Jin-Jie
    Lu, Zi-Jian
    Yan, Shu-Mei
    Yuan, Li
    Tang, Lin-Quan
    Li, Jian-Ming
    Mai, Hai-Qiang
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)